Michael T. Heffernan

2016

In 2016, Michael T. Heffernan earned a total compensation of $2.2M as President and Chief Executive Officer at Collegium Pharmaceutical, a 37% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$221,331
Option Awards$1,170,871
Salary$502,767
Stock Awards$290,644
Other$11,903
Total$2,197,516

Heffernan received $1.2M in option awards, accounting for 53% of the total pay in 2016.

Heffernan also received $221.3K in non-equity incentive plan, $502.8K in salary, $290.6K in stock awards and $11.9K in other compensation.

Rankings

In 2016, Michael T. Heffernan's compensation ranked 4,465th out of 14,075 executives tracked by ExecPay. In other words, Heffernan earned more than 68.3% of executives.

ClassificationRankingPercentile
All
4,465
out of 14,075
68th
Division
Manufacturing
1,573
out of 5,486
71st
Major group
Chemicals And Allied Products
479
out of 1,900
75th
Industry group
Drugs
351
out of 1,543
77th
Industry
Pharmaceutical Preparations
272
out of 1,173
77th
Source: SEC filing on April 13, 2017.

Heffernan's colleagues

We found five more compensation records of executives who worked with Michael T. Heffernan at Collegium Pharmaceutical in 2016.

2016

Michael Ph

Collegium Pharmaceutical

Chief Executive Officer

2016

Michael Ph

Collegium Pharmaceutical

Founder

2016

Paul Brannelly

Collegium Pharmaceutical

Chief Financial Officer

2016

Barry Duke

Collegium Pharmaceutical

Executive Vice President and Chief Commercial Officer

2016

Alison Fleming

Collegium Pharmaceutical

Chief Technology Officer

In-depth

You may also like